SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007881
Filing Date
2022-05-05
Accepted
2022-05-05 16:33:17
Documents
49
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q onct-20220331.htm   iXBRL 10-Q 1482282
2 EX-31.1 onct-ex31_1.htm EX-31.1 18950
3 EX-31.2 onct-ex31_2.htm EX-31.2 18933
4 EX-32.1 onct-ex32_1.htm EX-32.1 9132
5 EX-32.2 onct-ex32_2.htm EX-32.2 9534
  Complete submission text file 0000950170-22-007881.txt   5418700

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT onct-20220331_def.xml EX-101.DEF 141543
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT onct-20220331_cal.xml EX-101.CAL 22461
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT onct-20220331_pre.xml EX-101.PRE 242475
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT onct-20220331.xsd EX-101.SCH 44837
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT onct-20220331_lab.xml EX-101.LAB 343730
43 EXTRACTED XBRL INSTANCE DOCUMENT onct-20220331_htm.xml XML 883497
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 22896948
SIC: 2834 Pharmaceutical Preparations